Huber Nancy B 4

Accession 0001683168-21-001694

CIK 0001622879other

Filed

Apr 29, 8:00 PM ET

Accepted

Apr 30, 9:40 PM ET

Size

21.5 KB

Accession

0001683168-21-001694

Form 4

Period: 2019-12-05

Chief Financial Officer

Transactions

Disposition to Issuer
Employee Stock Option (Right to Buy)
2020-12-15−50,000→ 0 total
Exercise: $3.17Exp: 2029-08-18→ Common Stock (50,000 underlying)
Award
Employee Stock Option (Right to Buy)
2019-12-05+550,000→ 550,000 total
Exercise: $2.88Exp: 2029-12-04→ Common Stock (550,000 underlying)
Award
Employee Stock Option (Right to Buy)
2020-03-27+100,000→ 100,000 total
Exercise: $1.52Exp: 2030-03-26→ Common Stock (100,000 underlying)
Award
Employee Stock Option (Right to Buy)
2020-12-15+550,000→ 550,000 total
Exercise: $1.26Exp: 2030-12-14→ Common Stock (550,000 underlying)
Award
Employee Stock Option (Right to Buy)
2020-12-15+100,000→ 100,000 total
Exercise: $1.26Exp: 2030-12-14→ Common Stock (100,000 underlying)
Award
Employee Stock Option (Right to Buy)
2020-12-15+50,000→ 50,000 total
Exercise: $1.26Exp: 2030-12-14→ Common Stock (50,000 underlying)
Disposition to Issuer
Employee Stock Option (Right to Buy)
2020-12-15−100,000→ 0 total
Exercise: $1.52Exp: 2030-03-26→ Common Stock (100,000 underlying)
Disposition to Issuer
Employee Stock Option (Right to Buy)
2020-12-15−550,000→ 0 total
Exercise: $2.88Exp: 2029-12-04→ Common Stock (550,000 underlying)

Footnotes (7)

[F1]The options vest in four (4) equal installments on each anniversary of the grant date, beginning December 5, 2020.
[F2]The options vest in four (4) equal installments on each anniversary of the grant date, beginning on March 27, 2021.
[F3]The reporting person agreed to cancellation of (i) an option to purchase 550,000 shares of common stock granted to her on December 5, 2019, (ii) an option to purchase 100,000 shares of common stock granted to her on March 27, 2020, and (iii) an option to purchase 50,000 shares of common stock granted to her on August 19, 2019, in each case, for a new option having a lower exercise price.
[F4]25% of the option vested immediately upon grant on December 15, 2020. The remainder vest 25% beginning December 5, 2021 and the following two anniversaries of that date.
[F5]The option vest in 25% equal annual installments beginning 3/27/2021 and the following three anniversaries of that date.
[F6]25% of the option vested immediately upon grant on December 15, 2020. The remainder vest 25% beginning August 19, 2021 and the following two anniversaries of that date.
[F7]The options vest in four (4) equal installments on each anniversary of the grant date, beginning on August 19, 2021.

Documents

1 file

Medicine Man Technologies, Inc.

CIK 0001622879

Entity typeother